• Narrow screen resolution
  • Wide screen resolution
  • Decrease font size
  • Default font size
  • Increase font size


Diabetes Risk, Insulin Sensitivity and the Benefits of Barley Beta Glucan - An Interview With Joy L. Frestedt, PhD

frestedjoyheadshotLearn How Barley Beta-Glucan 'Water' Reduces Diabetes Risk and Insulin Sensitivity

Kirk Hamilton interviews Dr. Joy L. Frestedt a PhD in Laboratory Medicine and Pathology from the University of Minnesota Medical School; a certified clinical trial investigator; a fellow of the Regulatory Affairs Professionals Society; and is currently the president and CEO of Frestedt Incorporated which provides services in regulatory, clinical, and quality affairs. Dr. Frestedt is the co-author of a paper entitled: "Reduced Viscosity Barley Beta-Glucan Versus Placebo: A Randomized Controlled Trial of The Effects on Insulin Sensitivity for Individuals at Risk for Diabetes Mellitus," in the journal Nutrition and Metabolism in August of 2011.

Download or Open: Rx2000 Interviews

Dr. Joy Frestedt Interview Transcripts: Order Here More Transcripts

Play Online (12:45mm:ss):